| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |